The controversy of the treatment of critically ill patients with thyroid hormone
- 31 December 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 15 (4) , 465-477
- https://doi.org/10.1053/beem.2001.0164
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndromeJournal of Clinical Investigation, 2000
- Maternal Diabetes Mellitus, a Rat Model for Nonthyroidal Illness: Correction of Hypothyroxinemia with Thyroxine Treatment Does Not Improve Fetal Thyroid Hormone StatusThyroid®, 1997
- Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illnessCritical Care Medicine, 1994
- BENEFICIAL EFFECT OF COMBINED 3,5,3′-TRIIODOTHYRONINE AND VASOPRESSIN ADMINISTRATION ON HEPATIC ENERGY STATUS AND SYSTEMIC HEMODYNAMICS AFTER BRAIN DEATHTransplantation, 1992
- Facilitated Recovery of Cardiac Performance by Triiodothyronine following a Transient Ischemic InsultCardiology, 1992
- A246 HORMONAL THERAPY IN HUMAN BRAIN-DEAD POTENTIAL ORGAN DONORSAnesthesiology, 1990
- Alterations of serum concentrations of thyroid hormones and sex hormone-binding globulin, nuclear binding of tri-iodothyronine and thyroid hormone-stimulated cellular uptake of oxygen and glucose in mononuclear blood cells from patients with non-thyroidal illnessJournal of Endocrinology, 1990
- Effect of Tri-Iodothyronine Replacement on the Metabolic and Pituitary Responses to StarvationNew England Journal of Medicine, 1979
- The effect of intraamniotic thyroxine administration on fetal lung maturity in manjpme, 1979
- 3-Methylhistidine, a component of actinBiochemical and Biophysical Research Communications, 1967